海航科技(600751.SH):子公司天海物流的註冊資本擬減至300萬元
格隆匯7月19日丨海航科技(600751.SH)公吿,2021年7月16日,公司審議通過了《關於減少控股子公司天津天海物流投資管理有限公司註冊資本的議案》,公司子公司天津天海物流投資管理有限公司(“天海物流”)註冊資本擬由人民幣127.03億元減資到300萬元,公司及公司控股子公司上海標基投資合夥企業(有限合夥)(“上海標基”)擬分別按照持股比例對天海物流減資,公司減資金額為254萬元,上海標基減資金額為126.9746億元。
根據公司業務發展規劃,經研究,對天海物流進行減資有利於改善資產負債結構。同時,公司可集中資源進行戰略和業務轉型,提高股東回報,保護公司中小股東利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.